PlainRecalls
FDA Drug Moderate Class II Terminated

Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai Pharmaceutical Associates, Inc., Greenville, SC 29605; NDC 0121-0810-16.

Reported: April 1, 2020 Initiated: March 19, 2020 #D-1060-2020

Product Description

Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai Pharmaceutical Associates, Inc., Greenville, SC 29605; NDC 0121-0810-16.

Reason for Recall

SubPotent Drug: Low out-of-specification results for assay testing.

Details

Units Affected
7416 bottles
Distribution
Nationwide in the USA.
Location
Greenville, SC

Frequently Asked Questions

What product was recalled?
Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai Pharmaceutical Associates, Inc., Greenville, SC 29605; NDC 0121-0810-16.. Recalled by PAI Holdings, LLC. dba Pharmaceutical Associates Inc. Units affected: 7416 bottles.
Why was this product recalled?
SubPotent Drug: Low out-of-specification results for assay testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 1, 2020. Severity: Moderate. Recall number: D-1060-2020.